Monitor for further extensions or a definitive restructuring announcement by the October 22 deadline. The repeated short extensions suggest active negotiations but no imminent resolution.
Price Chart
Executive Summary
Karyopharm Therapeutics filed an 8-K to extend the forbearance period under its existing Forbearance Agreement and Limited Waiver to Indentures from October 15, 2026 to October 22, 2026. This is a procedural extension with no new financial details, indicating ongoing negotiations with noteholders but no resolution yet.
Key Facts
- Forbearance Period extended from October 15, 2026 to October 22, 2026.
- Extension made under Section 19 of the Forbearance Agreement dated September 10, 2026.
- No financial figures, restructuring terms, or new agreements disclosed.
Financial Impact
No financial impact disclosed; extension of forbearance period only.
Risk Factors
- Failure to reach a permanent agreement could trigger default under the indentures.
- Extended forbearance without resolution may signal deeper financial distress.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-421025 |
| Document: 0001193125-26-421025-index-headers.html | 0001193125-26-421025 |
| Document: 0001193125-26-421025-index.html | 0001193125-26-421025 |
| Document: 0001193125-26-421025.txt | 0001193125-26-421025 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $0.5175 | awaiting T+60 | — | $0.4800 (+7.25%) |
Oct 14, 2026 13d ago | 8-K | $0.3150 | awaiting T+60 | — | $0.4800 (+52.38%) |
Oct 8, 2026 19d ago | SC 13G/A | $0.6000 | awaiting T+60 | — | $0.4800 (+20.00%) |
Sep 25, 2026 4w ago | SC 13G/A | $1.62 | awaiting T+60 | — | $0.4800 (−70.37%) |
Sep 25, 2026 4w ago | SC 13G/A | $1.62 | awaiting T+60 | — | $0.4800 (−70.37%) |
Sep 11, 2026 6w ago | 8-K | $1.61 | awaiting T+60 | — | $0.4800 (+70.19%) |
Aug 31, 2026 8w ago | 8-K | $2.06 | awaiting T+60 | — | $0.4800 (−76.70%) |
Aug 13, 2026 10w ago | 8-K | $1.99 | awaiting T+60 | — | $0.4800 (+75.88%) |
Aug 10, 2026 11w ago | Press Release | $1.96 | awaiting T+60 | — | $0.4800 (−75.51%) |
Jul 31, 2026 12w ago | 8-K | $1.92 $0.4821 | ▼ −74.89% | ▼ −77.35% | $0.4800 (−75.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers